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EXPERIMENTAL THERAPY OF EPILEPSY WITH
TRANSCRANIAL MAGNETIC STIMULATION
Lack of additional benefit with
prolonged treatment
Joaquim P. Brasil-Neto1, Doralúcia P. de Araújo2, Wagner A. Teixeira3,
Valéria P. Araújo4, Raphael Boechat-Barros5
ABSTRACT - Objective: To investigate the effect of three months of low-frequency repetitive transcranial
magnetic stimulation (rTMS) treatment in intractable epilepsy. Methods: Five patients (four males, one
female; ages 6 to 50 years), were enrolled in the study; their epilepsy could not be controlled by medical
treatment and surgery was not indicated. rTMS was performed twice a week for three months; patients
kept records of seizure frequency for an equal period of time before, during, and after rTMS sessions.
rTMS was delivered to the vertex with a round coil, at an intensity 5 % below motor threshold. During
rTMS sessions, 100 stimuli (five series of 20 stimuli, with one-minute intervals between series) were deliv-
ered at a frequency of 0.3 Hz. Results: Mean daily number of seizures (MDNS) decreased in three patients
and increased in two during rTMS- one of these was treated for only one month; the best result was
achieved in a patient with focal cortical dysplasia (reduction of 43.09 % in MDNS). In the whole patient
group, there was a significant (p<0.01) decrease in MDNS of 22.8 %. Conclusions: Although prolonged
rTMS treatment is safe and moderately decreases MDNS in a group of patients with intractable epilepsy,
individual patient responses were mostly subtle and clinical relevance of this method is probably low. Our
data suggest, however, that patients with focal cortical lesions may indeed benefit from this novel treat-
ment. Further studies should concentrate on that patient subgroup. 
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Terapia experimental da epilepsia com estimulação magnética transcraniana: ausência de me-
lhora adicional com tratamento prolongado
RESUMO - Objetivo: investigar o efeito de três meses de estimulação magnética transcraniana repetitiva
(EMTr) de baixa freqüência, na epilepsia de difícil controle. Método: Cinco pacientes (quatro homens, uma
mulher, idades entre 6 e 50 anos), participaram do estudo; suas crises epilépticas não puderam ser contro-
lados por tratamento medicamentoso e não tinham indicação cirúrgica; a EMTr foi realizada duas vezes
por semana durante três meses, sendo que os pacientes anotaram o número diário de crises neste perío-
do, assim como nos três meses anteriores e posteriores ao tratamento. A aplicação da EMTr foi feita no
vértex com bobina circular, com intensidade 5% abaixo do limiar motor. Durante as sessões de EMTr, 100
estímulos (5 séries de 20 estímulos, com um minuto de intervalo entre as séries) foram realizadas na fre-
qüência de 0,3 Hz. Resultados: A média diária de crises (MDC) decresceu em três pacientes e aumentou
em dois durante o uso da EMTr; um destes casos foi tratado  somente por um mês; o melhor resultado foi
encontrado em um paciente com displasia cortical focal (redução de 43,09% na MDC). Em todo o grupo
de pacientes, houve decréscimo significativo na MDC de 22,8% (p<0,01). Conclusão: Embora o tratamen-
to prolongado com a EMTr seja seguro e tenha sido registrado decréscimo moderado da MDC em um
grupo de pacientes com epilepsia de difícil controle, respostas individuais de pacientes foram impre-
visíveis e a relevância clínica deste método é provavelmente baixa. Nossos dados sugerem, contudo, que
pacientes com lesões corticais focais podem ser beneficiar deste novo tipo de tratamento. Estudos futuros
devem se concentrar neste grupo de pacientes.
PALAVRAS-CHAVE: estimulação magnética transcraniana, EMTr, epilepsia.
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Since its introduction in 19851, transcranial
magnetic stimulation (TMS) has been used as a
neurophysiological research tool2-5 and more re-
cently, following studies that showed a significant
effect of repetitive transcranial magnetic stimu-
lation (rTMS) upon cortical excitability6-8 it has
also been considered for the treatment of patho-
logical conditions in which brain excitability is
probably abnormal, such as in writer’s cramp9 and
depression10. Modulation of cortical excitability by
TMS in epilepsy was first attempted as a means
of causing a silent epileptic focus to become acti-
ve; this would be useful in the pre-operative eva-
luation of epilepsy surgery patients. However, des-
pite encouraging initial results11 it was subsequen-
tly found that single pulse TMS rarely, if ever, in-
duces seizures, even in epileptic patients12. On
the other hand, repetitive, rapid-rate TMS may
precipitate seizures even in normal subjects, de-
pending on stimulus rate and intensity13. Low-
frequency rTMS appears to decrease cortical exci-
tability for some time after stimulation sessions14. 
Recently, two studies have used low-frequen-
cy rTMS as a means of decreasing cortical excita-
bility in epileptic patients15,16. Tergau et al.15 stud-
ied nine epileptic patients, using rTMS at a fre-
quency of 0.3 Hz, in daily sessions, for a period of
five days, and found a 20 % decrease in the mean
weekly number of seizures in one patient; other
three patients had a decrease between 20 and
50%, and another three subjects had a decrease
of over 50%. Comparisons were made between
one month periods immediately before and after
treatment.  Menkes and Gruenthal16 treated one
patient with focal cortical dysplasia with bi-wee-
kly low frequency (0.5 Hz) rTMS sessions for a pe-
riod of one month. Daily seizure frequency was
recorded for three months before rTMS sessions,
during the month of treatment and for another
month after the last experimental session. This
patient had a decrease of 70 % in the number of
seizures during the four weeks of rTMS treat-
ment, compared to the other two months. Since
epileptic patients may show spontaneous variabi-
lity in seizure frequency which often persists for
more than just a few weeks, these studies could
have been biased by these random fluctuations.
In a recent, randomized, blinded trial of rTMS in
patients with localization-related epilepsy, pati-
ents were also treated for only one week17. This
latter study had several important differences
with respect to the previous ones: it used a high-
er rTMS frequency (1 Hz), a butterfly coil and su-
prathreshold stimuli.
Therefore, we decided to study a smaller group
of patients, but to follow them for a much lon-
ger period of time, i.e., nine months (three months
of treatment, and equal periods of observation
before and after rTMS sessions). We also follo-
wed more closely the rTMS methods that had
proven successful in the initial studies by Tergau
et al.15 and Menkes and Gruenthal16.
METHOD
Five patients (four males, one female; ages 6 to 50
years) participated in the study. All had a diagnosis of
medically intractable epilepsy and surgery was not
indicated (one patient had already been operated on
without satisfactory results). All had very good compli-
ance with medical prescriptions. Table 1 summarises
the clinical data of all patients and EEG data are shown
in Table 2. Medications were not discontinued in any
patient, and were kept unchanged throughout the
whole study: four patients were on carbamazepine
(SLBS, LAFC, MOP and OM); LAFC also used topiramate
and OM, clobazam; RM was on lamotrigine, phenytoin
and phenobarbital.
The experimental protocol was approved by the
Health Sciences Faculty Ethics Commitee and all sub-
jects (or their parents in the case of the child) gave
written informed consent for the study. A Dantec
Mag-Lite® Magnetic Stimulator (Skovlunde, Denmark)
was used. Subjects sat comfortably on a chair. A round
coil was positioned over the Cz position of the interna-
tional 10-20 electrode placement system.
Prior to each session, motor threshold was deter-
mined; it was defined as the lowest intensity that pro-
duced a visible twitch of the relaxed abductor pollicis
brevis (APB) muscle following at least 3 out of 5 test
stimuli. When the coil was positioned with side A up-
wards (anti-clockwise current flow in the coil), the left
motor cortex was predominantly stimulated and the
twitch was more easily produced in the right APB; the
opposite was true for side B of the coil. In order to en-
sure equal treatment of both hemispheres, stimulating
sides were alternated between successive days of tre-
atment (e.g., if on the first day stimulation was done
with side A, on day 2 side B was used). A daily session
consisted of 5 sets of 20 stimuli each, delivered at a
frequency of 0.3 Hz at an intensity 5% below motor
threshold (i.e., if motor threshold was 45% of maximal
stimulator output, then stimulation was carried out at
40% of maximal stimulator output). Sets of 20 stimuli
were separated from one another by one minute in-
tervals. The first patient enrolled in the study, SLBS, was
treated for one month. However, due to the sponta-
neous variability in seizure frequency over relatively
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ing rTMS- one of these was treated for only one
month; the best result was achieved in a patient
with suspected focal cortical dysplasia (reduction
of 43.09% in MDNS). In the whole patient group,
there was a significant (p<0.01) decrease in MDNS
of 22.8 %.
Table 3 shows the mean number of seizures in
each patient before, during and after treatment,
as well as the results of statistical analysis. 
Although patient LAFC showed a steady de-
crease in MDNS during the whole experimental
period, this trend was not statistically significant;
MOP also had a decrease in MDNS that did not
reach statistical significance; RM, on the other
hand, showed a significant decrease in MDNS, fo-
llowed by an equally significant increase upon
discontinuation of the treatment. The remaining
two patients, SLBS and OMA, did not improve and
even increased their MDNS; this increase, howev-
er, was not statistically significant. 
Taking together the data from all patients,
MDNS was 1.426 (SE=0.089) before treatment,
1.100 (SE=0.073) during treatment and 1.613 (SE=
0.105) after treatment. MDNS during treatment
was significantly lower than before or after tre-
atment (ANOVA, p<0.01). 
An interesting result was obtained when a
long periods of time in this and other epileptic pati-
ents, we decided to increase treatment duration to 3
months in all subsequent patients. The number of dai-
ly seizures was recorded by the patients or their parents
in a diary especially designed for these experiments. A
comparison was made between seizure frequency in
the treatment period and in the three months preced-
ing and following rTMS treatment.
Repeated measures ANOVA was used for statistical
analysis, with significance limits set at p<0.01. Post-hoc
tests used included Scheffe F test, Dunnett t and Fisher
PLSD. Since each patient served as his own control,
mean daily number of seizures (MDNS) was compared
in the three periods (before, during and after rTMS)
both in individual patients (n= 270, i.e, the number of
days in nine months) and in the patient group as a
whole (n=1080, since the data for the patient who was
treated for only four weeks could not be used for that
analysis). 
We did not use sham stimulation because the pati-
ents were critically affected by their epilepsy, with daily
seizures, and there were two previous reports of sig-
nificant benefits of rTMS in epilepsy15,16. We felt it would
be unethical to deprive any patient from a treatment
that had been described as effective in the literature.
RESULTS
Mean daily number of seizures (MDNS) decre-
ased in three patients and increased in two dur-
Table 1. Clinical characteristics of the patients enrolled in the study.
Patient Age Sex Diagnostic  hypothesis Seizure characteristics
(Years)
SLBS 32 M Temporal focal epilepsy CPS (secondarily generalized),TCGS 
LAFC 19 M Frontal focal epilepsy CPS with complex automatisms
MOP 6 F Frontal focal epilepsy Asymetrical tonic seizures; CPS 
with complex automatisms
RM 30 M Frontal focal epilepsy Tonic  seizures
OMA 50 M Temporal focal epilepsy CPS and TCGS
CPS, complex partial seizures; TCGS, tonic-clonic generalized seizures
Table 2. Electroencephalographic characteristics of the patients enrolled in the study.
Patient Electroencephalographic findings
SLBS Left temporal slow activity and sharp waves
LAFC Left frontal slow activity and generalized sharp waves
MOP Left fronto-central slow activity ; no sharp waves
RM Bilateral frontal slow activity; no sharp waves
OMA Bilateral temporal slow activity and sharp waves
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comparison was made of the number of seizures
on the day immediately following an rTMS ses-
sion in the only patient who showed a significant
decrease in MDNS (RM): the mean number of sei-
zures on those particular days was significantly
lower when rTMS had been carried out with side
B of the coil facing upwards, thus stimulating pre-
ferentially the suspected pathological (right) ce-
rebral hemisphere. This difference is shown in
the Figure.
DISCUSSION
This study partially confirms previous obser-
vations that slow-rate rTMS is capable of decreas-
ing seizure frequency in epileptic patients15,17.
However, the reduction in seizure frequency was
not as impressive as in those studies, which em-
ployed short courses of rTMS treatment; our re-
sults are more in keeping with those of a recent
randomized, blinded trial, in which patients were
also treated for just one week, with slight reduc-
tions in seizure frequency16. Those authors specu-
late that maybe more prolonged periods of rTMS
treatment would result in more robust responses.
However, their methodology was quite different
from that employed in the other reported stud-
ies, including ours, and that may have been the
reason for their lack of more impressive results.
As to prolongation of treatment time, in spite of
having treated four patients for three months,
we have not found an enhancement of the previ-
ously described effects of rTMS.
There were no untoward effects from prolon-
ged rTMS treatment. There was a significant vari-
ability in the responses of individual patients to
rTMS: the patient who experienced the most sig-
nificant decrease in MDNS was RM, who has a
focal cortical dysplasia; this result is in accordance
with the report by Menkes and Gruenthal16, who
were able to produce a dramatic decrease in sei-
zure frequency in a patient with a similar lesion.
Theodore et al.17, although using different stimu-
lation frequencies, suprathreshold stimuli and a
butterfly coil, also point out a tendency for pati-
ents with neocortical rather than mesial foci to
have a greater mean reduction in seizure frequen-
cy. Consistent with that view, we have been able
to demonstrate a significant decrease in the num-
ber of seizures experienced by patient RM on the
days immediately following preferential stimula-
Figure. Mean number of seizures for patient RM on the days
immediately after rTMS, with either  side A of the coil facing
upwards (A) or side B positioned in the same way (B). Error
bars are standard deviations. The number of seizures was sig-
nificantly lower when side B was used (Student  t-test, p < 0.1).
This coil position preferentially stimulated the suspected pa-
thological (right) cerebral hemisphere.
Table 3. Mean daily number of seizures (MDNS) for each patient before, during and after rTMS treatment.
Patient pre TMS MDNS MDNS during TMS post TMS MDNS Significant
comparisons
(ANOVA, p <0.01)
SLBS 0.154 (SE=0.072) 0.192 (SE=0.079) 0.192 (SE=0.136) none
LAFC 0.506 (SE=0.124) 0.470 (SE=0.125) 0.361 (SE=0.087) none
MOP 1.951 (SE=0.137) 1.765 (SE=0.125) 1.852 (SE=0.140) none
RM 2.970 (SE=0.159) 1.690 (SE=0.152) 3.710 (SE=0.205) pre X during
pre X post
during X post
OMA 0.247 (SE=0.082) 0.432 (SE=0.111) 0.481 (SE=0.129) none
SE, standard errors.
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tion of the suspected pathological cerebral hemi-
sphere (Figure).
On the other hand, the two patients who sho-
wed a complete lack of improvement (SLBS and
OMA) either had extensive brain lesions (OMA)
or a lesion in a location which is certainly com-
pletely out of reach for rTMS (mesial temporal
sclerosis in patient SLBS).
Future research into this new treatment mo-
dality should probably concentrate on those pa-
tients with neocortical abnormalities and try to
apply focal rTMS to the pathological area, since
our study and those of Menkes and Gruenthal16
and even Theodore et al.17, all suggest that a clin-
ically significant effect would be more likely un-
der such circumstances. As far as other epileptic
disorders are concerned, however, our data sug-
gest an effect that, although interesting and sta-
tistically significant if this small and heteroge-
neous group of subjects is considered as a whole,
is not significant for individual patients and is of
doubtful clinical relevance. The one exception,
again, is the patient with a diagnostic hypothesis
of a neocortical lesion. 
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